410 related articles for article (PubMed ID: 20960483)
21. REM sleep behavior disorder, hallucinations, and cognitive impairment in Parkinson's disease.
Sinforiani E; Zangaglia R; Manni R; Cristina S; Marchioni E; Nappi G; Mancini F; Pacchetti C
Mov Disord; 2006 Apr; 21(4):462-6. PubMed ID: 16228998
[TBL] [Abstract][Full Text] [Related]
22. [Visual hallucinations in Parkinson and Charles Bonnet Syndrome patients. A phenomenological and pathogenetic comparison].
Diederich NJ; Pieri V; Goetz CG
Fortschr Neurol Psychiatr; 2000 Mar; 68(3):129-36. PubMed ID: 10758844
[TBL] [Abstract][Full Text] [Related]
23. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia.
Song IU; Kim JS; Jeong DS; Song HJ; Lee KS
Parkinsonism Relat Disord; 2008 Nov; 14(7):558-62. PubMed ID: 18328767
[TBL] [Abstract][Full Text] [Related]
24. [Cognition deterioration in Parkinson's disease: associated risk factors].
Errea JM; Ara JR
Rev Neurol; 1999 Mar 1-15; 28(5):439-43. PubMed ID: 10229953
[TBL] [Abstract][Full Text] [Related]
25. Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations.
Meppelink AM; de Jong BM; Teune LK; van Laar T
Mov Disord; 2011 Jan; 26(1):142-7. PubMed ID: 20922809
[TBL] [Abstract][Full Text] [Related]
26. Initial neuropsychological impairments in patients with the E46K mutation of the α-synuclein gene (PARK 1).
Somme JH; Gomez-Esteban JC; Molano A; Tijero B; Lezcano E; Zarranz JJ
J Neurol Sci; 2011 Nov; 310(1-2):86-9. PubMed ID: 21880335
[TBL] [Abstract][Full Text] [Related]
27. Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations.
Papapetropoulos S; McCorquodale DS; Gonzalez J; Jean-Gilles L; Mash DC
Parkinsonism Relat Disord; 2006 May; 12(4):253-6. PubMed ID: 16368258
[TBL] [Abstract][Full Text] [Related]
28. PDD-Short Screen: a brief cognitive test for screening dementia in Parkinson's disease.
Pagonabarraga J; Kulisevsky J; Llebaria G; García-Sánchez C; Pascual-Sedano B; Martinez-Corral M; Gironell A
Mov Disord; 2010 Mar; 25(4):440-6. PubMed ID: 20155863
[TBL] [Abstract][Full Text] [Related]
29. Cognitive dysfunctions and pathological gambling in patients with Parkinson's disease.
Santangelo G; Vitale C; Trojano L; Verde F; Grossi D; Barone P
Mov Disord; 2009 Apr; 24(6):899-905. PubMed ID: 19205072
[TBL] [Abstract][Full Text] [Related]
30. Neural correlates of minor hallucinations in non-demented patients with Parkinson's disease.
Pagonabarraga J; Soriano-Mas C; Llebaria G; López-Solà M; Pujol J; Kulisevsky J
Parkinsonism Relat Disord; 2014 Mar; 20(3):290-6. PubMed ID: 24373690
[TBL] [Abstract][Full Text] [Related]
31. Cut-off score of the Mattis Dementia Rating Scale for screening dementia in Parkinson's disease.
Llebaria G; Pagonabarraga J; Kulisevsky J; García-Sánchez C; Pascual-Sedano B; Gironell A; Martínez-Corral M
Mov Disord; 2008 Aug; 23(11):1546-50. PubMed ID: 18546326
[TBL] [Abstract][Full Text] [Related]
32. The epidemiology of dementia associated with Parkinson disease.
Aarsland D; Kurz MW
J Neurol Sci; 2010 Feb; 289(1-2):18-22. PubMed ID: 19733364
[TBL] [Abstract][Full Text] [Related]
33. Memory and executive function impairment predict dementia in Parkinson's disease.
Levy G; Jacobs DM; Tang MX; Côté LJ; Louis ED; Alfaro B; Mejia H; Stern Y; Marder K
Mov Disord; 2002 Nov; 17(6):1221-6. PubMed ID: 12465060
[TBL] [Abstract][Full Text] [Related]
34. [Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].
Martínez-Martín P; Prieto-Jurczynska C; Frades-Payo B
Rev Neurol; 2009 Oct 16-31; 49(8):393-8. PubMed ID: 19816841
[TBL] [Abstract][Full Text] [Related]
35. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.
Cahn-Weiner DA; Grace J; Ott BR; Fernandez HH; Friedman JH
Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):79-87. PubMed ID: 12050470
[TBL] [Abstract][Full Text] [Related]
36. Affective and cognitive Theory of Mind in patients with parkinson's disease.
Bodden ME; Mollenhauer B; Trenkwalder C; Cabanel N; Eggert KM; Unger MM; Oertel WH; Kessler J; Dodel R; Kalbe E
Parkinsonism Relat Disord; 2010 Aug; 16(7):466-70. PubMed ID: 20538499
[TBL] [Abstract][Full Text] [Related]
37. Cognitive deterioration rates in patients with Parkinson's disease from northeastern China.
Luo XG; Feng Y; Liu R; Yu HM; Wang L; Wu Z; Ren Y; He ZY
Dement Geriatr Cogn Disord; 2010; 30(1):64-70. PubMed ID: 20689285
[TBL] [Abstract][Full Text] [Related]
38. Neuropsychological correlates of theory of mind in patients with early Parkinson's disease.
Santangelo G; Vitale C; Trojano L; Errico D; Amboni M; Barbarulo AM; Grossi D; Barone P
Mov Disord; 2012 Jan; 27(1):98-105. PubMed ID: 21915910
[TBL] [Abstract][Full Text] [Related]
39. Assessment of hallucinations in Parkinson's disease using a novel scale.
Wada-Isoe K; Ohta K; Imamura K; Kitayama M; Nomura T; Yasui K; Nakaso K; Nakashima K
Acta Neurol Scand; 2008 Jan; 117(1):35-40. PubMed ID: 18095953
[TBL] [Abstract][Full Text] [Related]
40. Quetiapine improves visual hallucinations in Parkinson disease but not through normalization of sleep architecture: results from a double-blind clinical-polysomnography study.
Fernandez HH; Okun MS; Rodriguez RL; Malaty IA; Romrell J; Sun A; Wu SS; Pillarisetty S; Nyathappa A; Eisenschenk S
Int J Neurosci; 2009; 119(12):2196-205. PubMed ID: 19916848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
